Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000204618 | SCV000261677 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2015-10-28 | criteria provided, single submitter | clinical testing | |
| Mendelics | RCV000989862 | SCV001140460 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
| Illumina Laboratory Services, |
RCV000989862 | SCV001284847 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
| Gene |
RCV002508198 | SCV002818014 | uncertain significance | not provided | 2024-09-23 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Nucleotide substitution has no predicted effect on splicing and is not conserved across species; Located in a regulatory region; in the absence of functional studies, the actual effect of this sequence change is unknown; Observed in an individual with breast cancer and not observed among controls (PMID: 22753153); This variant is associated with the following publications: (PMID: 26332594, Brewster[Abstract]2012, 22753153) |
| Department of Pathology and Laboratory Medicine, |
RCV005361198 | SCV005917118 | likely pathogenic | Fanconi anemia, complementation group S | criteria provided, single submitter | clinical testing | ||
| BRCAlab, |
RCV000989862 | SCV004243899 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2020-03-02 | no assertion criteria provided | clinical testing |